# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001004726-26-003761
**Filing Date:** 2026-5
**Character Count:** 25754
**Document Hash:** 091189effcde310f51baaa506d1a0021
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001004726-26-003761.hdr.sgml**: 20260522

**ACCESSION NUMBER**: 0001004726-26-003761

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260522

**DATE AS OF CHANGE**: 20260522

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663

**ORGANIZATION NAME:**
- **EIN:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 261013216

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares U.S. Pharmaceuticals ETF (Series ID: S000009417)

| Class ID   | Class Name                       | Ticker Symbol   |
|:---|:---|:---|
| C000025771 | iShares U.S. Pharmaceuticals ETF | IHE             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares U.S. Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000009417

- **c. LEI of Series:** 549300K3OFF3L3ODU217

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1044611696.72

**Total Liabilities:** $43994522.75

**Net Assets:** $1000617173.97

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000025771 | 2.16%                | 6.04%                | -5.35%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $5744320.03              | $13862928.97                               |
| Month 2  | $964560.64               | $56780145.21                               |
| Month 3  | $7420020.61              | $-64523738.92                              |

### Schedule of Portfolio Investments

| Name                                                                       | Title                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Tarsus Pharmaceuticals Inc                                                 | TARSUS PHARMACEUTICALS INC                        | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    109154 | NS      | $7657153.10   | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| INNOVIVA, INC.                                                             | INNOVIVA INC                                      | CUSIP: 45781M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    198530 | NS      | $4625749.00   | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| XERIS BIOPHARMA HOLDINGS, INC.                                             | XERIS BIOPHARMA HOLDINGS INC                      | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    463758 | NS      | $2689796.40   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                                                | ARVINAS INC                                       | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    179506 | NS      | $1902763.60   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | CUSIP: 066922519<br>LEI: N/A                  | Long             | STIV             | RF                | US        |  43573039 | NS      | $43581753.17  | 4.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                                                   | ENLIVEN THERAPEUTICS INC                          | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    124406 | NS      | $4876715.20   | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| LENZ Therapeutics Inc                                                      | LENZ THERAPEUTICS INC                             | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61219 | NS      | $560153.85    | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| INDIVIOR PHARMACEUTICALS, INC.                                             | INDIVIOR PHARMACEUTICALS INC                      | CUSIP: 45579U109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    348967 | NS      | $10636514.16  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| ORGANON & CO.                                                              | ORGANON CO                                        | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    726652 | NS      | $4352645.48   | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                                                           | NUVATION BIO INC                                  | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    668795 | NS      | $2869130.55   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| BRISTOL-MYERS SQUIBB COMPANY                                               | BRISTOL MYERS SQUIBB CO                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    763754 | NS      | $46321680.10  | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI PHARMACEUTICALS, INC.                                                  | ANI PHARMACEUTICALS INC                           | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     50247 | NS      | $3863994.30   | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| PFIZER INC.                                                                | PFIZER INC                                        | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   1678022 | NS      | $47118857.76  | 4.71%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK & CO., INC.                                                          | MERCK CO INC                                      | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    394200 | NS      | $47418318.00  | 4.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Definium Therapeutics Inc                                                  | DEFINIUM THERAPEUTICS INC                         | CUSIP: 24477V105<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |    275332 | NS      | $5203774.80   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| ROYALTY PHARMA PLC                                                         | ROYALTY PHARMA PLC                                | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    981152 | NS      | $47065861.44  | 4.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals Inc                                                 | AMYLYX PHARMACEUTICALS INC                        | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    233280 | NS      | $3242592.00   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| OCULAR THERAPEUTIX, INC.                                                   | OCULAR THERAPEUTIX INC                            | CUSIP: 67576A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    486759 | NS      | $4122848.73   | 0.41%             |  |  |  | No            |                  1 | On Loan: —       |
| NEKTAR THERAPEUTICS                                                        | NEKTAR THERAPEUTICS                               | CUSIP: 640268306<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78204 | NS      | $5626777.80   | 0.56%             |  |  |  | No            |                  1 | On Loan: —       |
| Edgewise Therapeutics Inc                                                  | EDGEWISE THERAPEUTICS INC                         | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    207131 | NS      | $6524626.50   | 0.65%             |  |  |  | No            |                  1 | On Loan: —       |
| ELI LILLY AND COMPANY                                                      | ELI LILLY CO                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    229087 | NS      | $210707349.99 | 21.06%            |  |  |  | No            |                  1 | On Loan: No      |
| WAVE Life Sciences Ltd                                                     | WAVE LIFE SCIENCES LTD                            | CUSIP: Y95308105<br>LEI: N/A                  | Long             | EC               | CORP              | SG        |    404066 | NS      | $2929478.50   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| CORCEPT THERAPEUTICS INCORPORATED                                          | CORCEPT THERAPEUTICS INC                          | CUSIP: 218352102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    261660 | NS      | $10547514.60  | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY                                | JAZZ PHARMACEUTICALS PLC                          | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |    169838 | NS      | $32107873.90  | 3.21%             |  |  |  | No            |                  1 | On Loan: No      |
| PHIBRO ANIMAL HEALTH CORPORATION                                           | PHIBRO ANIMAL HEALTH CORP                         | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |     57644 | NS      | $3188289.64   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| CORMEDIX INC.                                                              | CORMEDIX INC                                      | CUSIP: 21900C308<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    204800 | NS      | $1390592.00   | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| THERAVANCE BIOPHARMA, INC.                                                 | THERAVANCE BIOPHARMA INC                          | CUSIP: G8807B106<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |    103389 | NS      | $1678003.47   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp                                                              | LIQUIDIA CORP                                     | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    192090 | NS      | $7249476.60   | 0.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Septerna Inc                                                               | SEPTERNA INC                                      | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     63823 | NS      | $1533666.69   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| XAV HEALTH CARE JUN26                                                      | XAV HEALTH CARE JUN26                             | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |         8 | NC      | $-33487.98    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| ELANCO ANIMAL HEALTH INCORPORATED                                          | ELANCO ANIMAL HEALTH INC                          | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |   1388731 | NS      | $33232332.83  | 3.32%             |  |  |  | No            |                  1 | On Loan: —       |
| Rapport Therapeutics Inc                                                   | RAPPORT THERAPEUTICS INC                          | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     79927 | NS      | $2500915.83   | 0.25%             |  |  |  | No            |                  1 | On Loan: —       |
| Alumis Inc                                                                 | ALUMIS INC                                        | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    226551 | NS      | $4990918.53   | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| PACIRA BIOSCIENCES, INC.                                                   | PACIRA BIOSCIENCES INC                            | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    114720 | NS      | $2592672.00   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| HARMONY BIOSCIENCES HOLDINGS, INC.                                         | HARMONY BIOSCIENCES HOLDINGS INC                  | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    111077 | NS      | $3111266.77   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| EYEPOINT, INC.                                                             | EYEPOINT INC                                      | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |    217506 | NS      | $2803652.34   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                                                                 | EVOLUS INC                                        | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |    181171 | NS      | $744612.81    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| AXSOME THERAPEUTICS, INC.                                                  | AXSOME THERAPEUTICS INC                           | CUSIP: 05464T104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    118359 | NS      | $20005038.18  | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| LIGAND PHARMACEUTICALS INCORPORATED                                        | LIGAND PHARMACEUTICALS                            | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     55011 | NS      | $10982946.15  | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| HARROW, INC.                                                               | HARROW INC                                        | CUSIP: 415858109<br>LEI: 529900AP4LIRLNV8A089 | Long             | EC               | CORP              | US        |     92131 | NS      | $3248539.06   | 0.32%             |  |  |  | No            |                  1 | On Loan: —       |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares      | BLACKROCK CASH FUNDS TREASURY                     | CUSIP: 066922477<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    901594 | NS      | $901593.79    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| JOHNSON & JOHNSON                                                          | JOHNSON JOHNSON                                   | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    942632 | NS      | $230416966.08 | 23.03%            |  |  |  | No            |                  1 | On Loan: No      |
| LB Pharmaceuticals Inc                                                     | LB PHARMACEUTICALS INC                            | CUSIP: 50180M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     67960 | NS      | $1675893.60   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY                                     | PERRIGO CO PLC                                    | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    384659 | NS      | $4131237.66   | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc                                              | CRINETICS PHARMACEUTICALS INC                     | CUSIP: 22663K107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    286520 | NS      | $10406406.40  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc                                                  | TERNS PHARMACEUTICALS INC                         | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |    240429 | NS      | $12675416.88  | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| AMPHASTAR PHARMACEUTICALS, INC.                                            | AMPHASTAR PHARMACEUTICALS INC                     | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |     98895 | NS      | $1937353.05   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| VIATRIS INC.                                                               | VIATRIS INC                                       | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   3219194 | NS      | $43491310.94  | 4.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Maze Therapeutics Inc                                                      | MAZE THERAPEUTICS INC                             | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     59177 | NS      | $1766433.45   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences Inc                                                        | MBX BIOSCIENCES INC                               | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70280 | NS      | $2097858.00   | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| OMEROS CORPORATION                                                         | OMEROS CORP                                       | CUSIP: 682143102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    198165 | NS      | $2092622.40   | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| BIOAGE Labs Inc                                                            | BIOAGE LABS INC                                   | CUSIP: 09077V100<br>LEI: 529900NG0C40250Z7875 | Long             | EC               | CORP              | US        |     84022 | NS      | $1469544.78   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| SUPERNUS PHARMACEUTICALS, INC.                                             | SUPERNUS PHARMACEUTICALS INC                      | CUSIP: 868459108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    160263 | NS      | $8283994.47   | 0.83%             |  |  |  | No            |                  1 | On Loan: —       |
| PRESTIGE CONSUMER HEALTHCARE INC.                                          | PRESTIGE CONSUMER HEALTH                          | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    132257 | NS      | $7838872.39   | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| ZOETIS INC.                                                                | ZOETIS INC                                        | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    382419 | NS      | $45205749.99  | 4.52%             |  |  |  | No            |                  1 | On Loan: No      |
| AMNEAL PHARMACEUTICALS, INC.                                               | AMNEAL PHARMACEUTICALS INC                        | CUSIP: 03168L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    474468 | NS      | $5897637.24   | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc                                                     | TREVI THERAPEUTICS INC                            | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    290306 | NS      | $3463350.58   | 0.35%             |  |  |  | No            |                  1 | On Loan: —       |
| PHATHOM PHARMACEUTICALS, INC.                                              | PHATHOM PHARMACEUTICALS INC                       | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    139379 | NS      | $1548500.69   | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Collegium Pharmaceutical, Inc.                                             | COLLEGIUM PHARMACEUTICAL INC                      | CUSIP: 19459J104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     88352 | NS      | $2921800.64   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-04-30

**Name of Applicant:** iShares Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer